Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AFYA
Afya Ltd.
|
$172.3M | $0.33 | 17.32% | 26.81% | $18.95 |
|
ABEV
Ambev SA
|
$4B | $0.04 | -1.18% | 2.68% | $2.88 |
|
LND
BrasilAgro Cia Brasileira de Propriedades Agricolas
|
$56.3M | -- | -2.71% | -- | -- |
|
MRVSY
Minerva SA
|
-- | -- | -- | -- | -- |
|
SLCJY
SLC Agricola SA
|
-- | -- | -- | -- | -- |
|
VSTA
Vasta Platform Ltd.
|
$53.7M | -$0.05 | 35.34% | -73.73% | $3.54 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AFYA
Afya Ltd.
|
$14.66 | $18.95 | $1.3B | 10.70x | $0.23 | 1.58% | 2.13x |
|
ABEV
Ambev SA
|
$2.37 | $2.88 | $36.9B | 13.20x | $0.13 | 5.5% | 2.35x |
|
LND
BrasilAgro Cia Brasileira de Propriedades Agricolas
|
$3.58 | -- | $356.6M | 14.88x | $0.14 | 3.95% | 2.38x |
|
MRVSY
Minerva SA
|
$3.99 | -- | $981.5M | 57.09x | $0.15 | 0% | 0.10x |
|
SLCJY
SLC Agricola SA
|
$3.02 | -- | $1.3B | 11.76x | $0.16 | 8.44% | 0.92x |
|
VSTA
Vasta Platform Ltd.
|
$4.95 | $3.54 | $398M | 4.92x | $0.00 | 0% | 1.32x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AFYA
Afya Ltd.
|
38.53% | -0.990 | 39.28% | 0.97x |
|
ABEV
Ambev SA
|
3.05% | -1.169 | 3.61% | 0.69x |
|
LND
BrasilAgro Cia Brasileira de Propriedades Agricolas
|
38.69% | -0.087 | 66.08% | 0.82x |
|
MRVSY
Minerva SA
|
95.39% | 0.982 | 397.38% | 1.03x |
|
SLCJY
SLC Agricola SA
|
67.42% | -0.377 | 137.58% | 0.34x |
|
VSTA
Vasta Platform Ltd.
|
15.31% | -1.811 | 41.41% | 1.13x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AFYA
Afya Ltd.
|
$108M | $52.2M | 9.65% | 16.42% | 30.62% | $61.7M |
|
ABEV
Ambev SA
|
$1.8B | $896.3M | 16.4% | 16.95% | 23.43% | $1.1B |
|
LND
BrasilAgro Cia Brasileira de Propriedades Agricolas
|
$23.2M | $4M | -0.73% | -1.16% | 7.11% | $20.3M |
|
MRVSY
Minerva SA
|
$453.6M | $203.7M | -2.65% | -69.14% | 7.16% | $545.3M |
|
SLCJY
SLC Agricola SA
|
$94.4M | $40.6M | 3.91% | 11.37% | 11.01% | $150.4M |
|
VSTA
Vasta Platform Ltd.
|
$31.1M | -$7.4M | 8.12% | 9.6% | -16.11% | $14.6M |
Ambev SA has a net margin of 17.17% compared to Afya Ltd.'s net margin of 23.33%. Afya Ltd.'s return on equity of 16.42% beat Ambev SA's return on equity of 16.95%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
AFYA
Afya Ltd.
|
63.39% | $0.31 | $1.5B |
|
ABEV
Ambev SA
|
47.92% | $0.06 | $18B |
Afya Ltd. has a consensus price target of $18.95, signalling upside risk potential of 26.37%. On the other hand Ambev SA has an analysts' consensus of $2.88 which suggests that it could grow by 21.47%. Given that Afya Ltd. has higher upside potential than Ambev SA, analysts believe Afya Ltd. is more attractive than Ambev SA.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
AFYA
Afya Ltd.
|
2 | 2 | 2 |
|
ABEV
Ambev SA
|
1 | 8 | 1 |
Afya Ltd. has a beta of 0.516, which suggesting that the stock is 48.399% less volatile than S&P 500. In comparison Ambev SA has a beta of 0.706, suggesting its less volatile than the S&P 500 by 29.392%.
Afya Ltd. has a quarterly dividend of $0.23 per share corresponding to a yield of 1.58%. Ambev SA offers a yield of 5.5% to investors and pays a quarterly dividend of $0.13 per share. Afya Ltd. pays -- of its earnings as a dividend. Ambev SA pays out 60.2% of its earnings as a dividend. Ambev SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Afya Ltd. quarterly revenues are $170.4M, which are smaller than Ambev SA quarterly revenues of $3.8B. Afya Ltd.'s net income of $29.3M is lower than Ambev SA's net income of $892.6M. Notably, Afya Ltd.'s price-to-earnings ratio is 10.70x while Ambev SA's PE ratio is 13.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya Ltd. is 2.13x versus 2.35x for Ambev SA. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
AFYA
Afya Ltd.
|
2.13x | 10.70x | $170.4M | $29.3M |
|
ABEV
Ambev SA
|
2.35x | 13.20x | $3.8B | $892.6M |
BrasilAgro Cia Brasileira de Propriedades Agricolas has a net margin of 17.17% compared to Afya Ltd.'s net margin of -21.17%. Afya Ltd.'s return on equity of 16.42% beat BrasilAgro Cia Brasileira de Propriedades Agricolas's return on equity of -1.16%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
AFYA
Afya Ltd.
|
63.39% | $0.31 | $1.5B |
|
LND
BrasilAgro Cia Brasileira de Propriedades Agricolas
|
41.6% | -$0.12 | $644.2M |
Afya Ltd. has a consensus price target of $18.95, signalling upside risk potential of 26.37%. On the other hand BrasilAgro Cia Brasileira de Propriedades Agricolas has an analysts' consensus of -- which suggests that it could fall by --. Given that Afya Ltd. has higher upside potential than BrasilAgro Cia Brasileira de Propriedades Agricolas, analysts believe Afya Ltd. is more attractive than BrasilAgro Cia Brasileira de Propriedades Agricolas.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
AFYA
Afya Ltd.
|
2 | 2 | 2 |
|
LND
BrasilAgro Cia Brasileira de Propriedades Agricolas
|
0 | 0 | 0 |
Afya Ltd. has a beta of 0.516, which suggesting that the stock is 48.399% less volatile than S&P 500. In comparison BrasilAgro Cia Brasileira de Propriedades Agricolas has a beta of 0.286, suggesting its less volatile than the S&P 500 by 71.382%.
Afya Ltd. has a quarterly dividend of $0.23 per share corresponding to a yield of 1.58%. BrasilAgro Cia Brasileira de Propriedades Agricolas offers a yield of 3.95% to investors and pays a quarterly dividend of $0.14 per share. Afya Ltd. pays -- of its earnings as a dividend. BrasilAgro Cia Brasileira de Propriedades Agricolas pays out 50.19% of its earnings as a dividend. BrasilAgro Cia Brasileira de Propriedades Agricolas's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Afya Ltd. quarterly revenues are $170.4M, which are larger than BrasilAgro Cia Brasileira de Propriedades Agricolas quarterly revenues of $55.7M. Afya Ltd.'s net income of $29.3M is higher than BrasilAgro Cia Brasileira de Propriedades Agricolas's net income of -$11.8M. Notably, Afya Ltd.'s price-to-earnings ratio is 10.70x while BrasilAgro Cia Brasileira de Propriedades Agricolas's PE ratio is 14.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya Ltd. is 2.13x versus 2.38x for BrasilAgro Cia Brasileira de Propriedades Agricolas. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
AFYA
Afya Ltd.
|
2.13x | 10.70x | $170.4M | $29.3M |
|
LND
BrasilAgro Cia Brasileira de Propriedades Agricolas
|
2.38x | 14.88x | $55.7M | -$11.8M |
Minerva SA has a net margin of 17.17% compared to Afya Ltd.'s net margin of 0.77%. Afya Ltd.'s return on equity of 16.42% beat Minerva SA's return on equity of -69.14%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
AFYA
Afya Ltd.
|
63.39% | $0.31 | $1.5B |
|
MRVSY
Minerva SA
|
15.93% | $0.07 | $5.4B |
Afya Ltd. has a consensus price target of $18.95, signalling upside risk potential of 26.37%. On the other hand Minerva SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Afya Ltd. has higher upside potential than Minerva SA, analysts believe Afya Ltd. is more attractive than Minerva SA.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
AFYA
Afya Ltd.
|
2 | 2 | 2 |
|
MRVSY
Minerva SA
|
0 | 0 | 0 |
Afya Ltd. has a beta of 0.516, which suggesting that the stock is 48.399% less volatile than S&P 500. In comparison Minerva SA has a beta of -0.094, suggesting its less volatile than the S&P 500 by 109.43%.
Afya Ltd. has a quarterly dividend of $0.23 per share corresponding to a yield of 1.58%. Minerva SA offers a yield of 0% to investors and pays a quarterly dividend of $0.15 per share. Afya Ltd. pays -- of its earnings as a dividend. Minerva SA pays out -- of its earnings as a dividend.
Afya Ltd. quarterly revenues are $170.4M, which are smaller than Minerva SA quarterly revenues of $2.8B. Afya Ltd.'s net income of $29.3M is higher than Minerva SA's net income of $22M. Notably, Afya Ltd.'s price-to-earnings ratio is 10.70x while Minerva SA's PE ratio is 57.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya Ltd. is 2.13x versus 0.10x for Minerva SA. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
AFYA
Afya Ltd.
|
2.13x | 10.70x | $170.4M | $29.3M |
|
MRVSY
Minerva SA
|
0.10x | 57.09x | $2.8B | $22M |
SLC Agricola SA has a net margin of 17.17% compared to Afya Ltd.'s net margin of -0.72%. Afya Ltd.'s return on equity of 16.42% beat SLC Agricola SA's return on equity of 11.37%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
AFYA
Afya Ltd.
|
63.39% | $0.31 | $1.5B |
|
SLCJY
SLC Agricola SA
|
25.61% | -$0.00 | $3B |
Afya Ltd. has a consensus price target of $18.95, signalling upside risk potential of 26.37%. On the other hand SLC Agricola SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Afya Ltd. has higher upside potential than SLC Agricola SA, analysts believe Afya Ltd. is more attractive than SLC Agricola SA.
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
AFYA
Afya Ltd.
|
2 | 2 | 2 |
|
SLCJY
SLC Agricola SA
|
0 | 0 | 0 |
Afya Ltd. has a beta of 0.516, which suggesting that the stock is 48.399% less volatile than S&P 500. In comparison SLC Agricola SA has a beta of 0.400, suggesting its less volatile than the S&P 500 by 60.029%.
Afya Ltd. has a quarterly dividend of $0.23 per share corresponding to a yield of 1.58%. SLC Agricola SA offers a yield of 8.44% to investors and pays a quarterly dividend of $0.16 per share. Afya Ltd. pays -- of its earnings as a dividend. SLC Agricola SA pays out 31.11% of its earnings as a dividend. SLC Agricola SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Afya Ltd. quarterly revenues are $170.4M, which are smaller than SLC Agricola SA quarterly revenues of $368.6M. Afya Ltd.'s net income of $29.3M is higher than SLC Agricola SA's net income of -$2.7M. Notably, Afya Ltd.'s price-to-earnings ratio is 10.70x while SLC Agricola SA's PE ratio is 11.76x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya Ltd. is 2.13x versus 0.92x for SLC Agricola SA. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
AFYA
Afya Ltd.
|
2.13x | 10.70x | $170.4M | $29.3M |
|
SLCJY
SLC Agricola SA
|
0.92x | 11.76x | $368.6M | -$2.7M |
Vasta Platform Ltd. has a net margin of 17.17% compared to Afya Ltd.'s net margin of -23.91%. Afya Ltd.'s return on equity of 16.42% beat Vasta Platform Ltd.'s return on equity of 9.6%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
AFYA
Afya Ltd.
|
63.39% | $0.31 | $1.5B |
|
VSTA
Vasta Platform Ltd.
|
67.92% | -$0.14 | $1.1B |
Afya Ltd. has a consensus price target of $18.95, signalling upside risk potential of 26.37%. On the other hand Vasta Platform Ltd. has an analysts' consensus of $3.54 which suggests that it could fall by -28.52%. Given that Afya Ltd. has higher upside potential than Vasta Platform Ltd., analysts believe Afya Ltd. is more attractive than Vasta Platform Ltd..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
AFYA
Afya Ltd.
|
2 | 2 | 2 |
|
VSTA
Vasta Platform Ltd.
|
0 | 1 | 1 |
Afya Ltd. has a beta of 0.516, which suggesting that the stock is 48.399% less volatile than S&P 500. In comparison Vasta Platform Ltd. has a beta of -0.276, suggesting its less volatile than the S&P 500 by 127.647%.
Afya Ltd. has a quarterly dividend of $0.23 per share corresponding to a yield of 1.58%. Vasta Platform Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Afya Ltd. pays -- of its earnings as a dividend. Vasta Platform Ltd. pays out -- of its earnings as a dividend.
Afya Ltd. quarterly revenues are $170.4M, which are larger than Vasta Platform Ltd. quarterly revenues of $45.8M. Afya Ltd.'s net income of $29.3M is higher than Vasta Platform Ltd.'s net income of -$11M. Notably, Afya Ltd.'s price-to-earnings ratio is 10.70x while Vasta Platform Ltd.'s PE ratio is 4.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Afya Ltd. is 2.13x versus 1.32x for Vasta Platform Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
AFYA
Afya Ltd.
|
2.13x | 10.70x | $170.4M | $29.3M |
|
VSTA
Vasta Platform Ltd.
|
1.32x | 4.92x | $45.8M | -$11M |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.